Epidemiological studies on A-T families showed that heterozygous ATM deleterious variant carriers (hereafter referred to as HetAT) are also at increased risk of other cancer types [4–6], notably of breast cancer (BC) in female relatives [7, 8]. Here, ATM is linked to breast carcinoma.